Nextage Therapeutics Ltd. Logo

Nextage Therapeutics Ltd.

Develops cannabinoid-based therapeutics using a proprietary drug delivery platform.

NXTG | TA

Overview

Description

Nextage Therapeutics Ltd. is a pharmaceutical company focused on the development of cannabinoid-based therapeutic products. The company utilizes a proprietary drug delivery platform, including a brain-targeting liposome system, to enhance the delivery and efficacy of active pharmaceutical ingredients. Originating from Nextar Chempharma Solutions, a contract development and manufacturing organization (CDMO), Nextage leverages expertise in chemical and product development to create innovative treatments. The company's activities also include providing product development services within the pharmaceutical sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-09-28 11:29
Suspension of trade due to failure in publishing financial reports-Notification
English PDF 130.4 KB
2025-04-08 19:36
The sector classification of NEXTAGE THERAPEUTICS will be changed, as of April …
Hebrew (modern) PDF 104.0 KB
2025-01-19 13:36
Discontinuation of Market Making
Hebrew (modern) PDF 119.8 KB
2022-02-02 17:02
Opening of Trading On February 3 2022-NEXTAGE W27
Hebrew (modern) PDF 255.8 KB
2022-02-01 15:14
Identifying Details of New Security- NEXTAGE W27
Hebrew (modern) PDF 88.6 KB
2021-02-09 15:18
On Wednesday, Feruary 10 2021, trading will commence in the following security:…
Hebrew (modern) PDF 175.0 KB
2021-01-28 19:11
Rights Offering and Identifying Details for New Securities: NEXTAGE R1, NEXTAGE…
Hebrew (modern) PDF 246.1 KB
2020-08-26 15:24
CHANGES IN COMPANY'S AND SECURITIES NAMES EFFECTIVE OF August 30, 2020
Hebrew (modern) PDF 171.2 KB
2020-08-13 20:02
Further to completion of a big allotment and in light of compliance with TASE's…
Hebrew (modern) PDF 94.0 KB

Automate Your Workflow. Get a real-time feed of all Nextage Therapeutics Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nextage Therapeutics Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nextage Therapeutics Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ALTIA Logo
Provides digital consulting, development, and maintenance solutions for various sectors.
Spain
ALC
Amanet Management & Systems Ltd. Logo
A systems house offering project management, software, IT, and consulting services.
Israel
AMAN
AMDOCS LTD Logo
Provider of software and services for communications, media, and entertainment companies.
United States of America
DOX
AMTD Digital Inc. Logo
A digital solutions platform for finance, media, investments, and hospitality services.
United States of America
HKD
Aplicaciones Y Tratamientos De Sistemas S.A. Logo
An IT company specializing in consulting, services, and software development.
Spain
ATSI
A PN Promise Spolka Akcyjna Logo
IT solutions provider specializing in digital transformation using Microsoft technologies.
Poland
PRO
Manufactures and sells custom PCs, components, and servers, offering IT services.
Japan
3020
AR advanced technology, Inc. Logo
Specializes in digital transformation solutions using cloud, data analysis, and AI.
Japan
5578
ARB IOT Group Ltd Logo
Provider of end-to-end IoT integration solutions and specialized AI hardware.
United States of America
ARBB
ARCONTECH GROUP PLC Logo
Develops real-time market data software for financial institutions and regulators.
United Kingdom
ARC

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.